Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Atul J. Butte, Chief of the Division of Systems Medicine at Stanford University School of Medicine, explains why it’s an amazing time right now for biomedical research. As…
Larry Smarr, Founding Director, CALIT2, details the growing epidemic of children, especially those with gastrointestinal disorders, who were not exposed to the necessary microbiomes during the formative years…
John Abele, Founder, Boston Scientific Corporation, explains the challenges behind the exponential growth in the advancement of technology. He gives 6 guidelines to address the ethical dilemmas of modern…
Larry Smarr, Founding Director, CALIT2, examines the 90% of cells in the body that aren’t human, most of which reside in the large intestine. A recent study used…
How do small companies create groundbreaking changes through the internet? Brad Templeton of Foresight Nanotech Institute and former chairman of Electronic Frontier Foundation explains how “stupid networks” allow…
Why try to develop new drugs and therapies when we can repurpose old ones? Atul J. Butte, MD, PhD, Chief of Division of Systems Medicine at Stanford School…
Neil Jacobstein, Co-Chair of A.I. and Robotics, Singularity University, discusses the implications of introducing physician’s assistant AI mobile devices as a clinical decision support package for physicians. The…
John Abele, Co-Founder and Director or Boston Scientific, talks about how while people know when they aren’t feeling well, it’s often difficult to understand why. Doctors can use…
John Abele, Founder, Boston Scientific Corporation, discusses the dilemma of regulating medicine when it comes to the risk of not doing something versus the risk of doing something.…
Chris Longhurst, MD, Associate Professor, Stanford Medical School, gives insight on the future of a fully digital healthcare system. By 2020, a nationwide learning healthcare system will allow…
